151 related articles for article (PubMed ID: 10707123)
1. Beta-lactamase activity of anaerobic bacteroides strains isolated from clinical samples and their susceptibility to antimicrobial agents.
Uraz G; Türkmen L
Drug Metabol Drug Interact; 1999; 15(2-3):181-6. PubMed ID: 10707123
[TBL] [Abstract][Full Text] [Related]
2. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
5. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
Jacobs MR; Spangler SK; Appelbaum PC
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1081-93. PubMed ID: 1295763
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Downes J; Andrew JH
Pathology; 1988 Jul; 20(3):260-3. PubMed ID: 3205597
[TBL] [Abstract][Full Text] [Related]
7. Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol.
Cordero-Laurent E; Rodríguez C; Rodríguez-Cavallini E; Gamboa-Coronado MM; Quesada-Gómez C
Rev Esp Quimioter; 2012 Dec; 25(4):261-5. PubMed ID: 23303257
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
van der Westhuyzen I; Chalkley LJ
S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
[TBL] [Abstract][Full Text] [Related]
9. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
10. Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1991 Jun; 35(6):1214-8. PubMed ID: 1929264
[TBL] [Abstract][Full Text] [Related]
11. Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.
Lacroix JM; Lamothe F; Malouin F
Antimicrob Agents Chemother; 1984 Nov; 26(5):694-8. PubMed ID: 6335019
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
Jacobs MR; Spangler SK; Appelbaum PC
Eur J Clin Microbiol Infect Dis; 1990 Jun; 9(6):417-21. PubMed ID: 2387295
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of amoxycillin plus clavulanic acid and ticarcillin plus clavulanic acid compared with that of other antibiotics against anaerobic bacteria.
Pierard D; De Meyer A; Rosseel P; Glupczynski Y; Struelens MJ; Delmee M; Pattyn SR; Verschraegen G; Melin P; Lauwers S
Acta Clin Belg; 1989; 44(4):228-36. PubMed ID: 2618522
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
Cáceres M; Carera E; Palmgren AC; Nord CE
Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
[TBL] [Abstract][Full Text] [Related]
15. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
Nagy E; Szóke I; Gacs M; Csiszár K
Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of the species of genus bacteroides recently isolated from clinical specimens to 20 antimicrobial agents.
Nasu M; Nakatomi M; Saito A; Hara K
Arzneimittelforschung; 1981; 31(5):764-70. PubMed ID: 7196732
[TBL] [Abstract][Full Text] [Related]
17. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary.
Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E
Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023
[TBL] [Abstract][Full Text] [Related]
18. Characterization of beta-lactamases in clinical isolates of Bacteroides.
Eley A; Greenwood D
J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
[TBL] [Abstract][Full Text] [Related]
19. German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study Group.
Rodloff AC; Werner H; Kresken M; Jansen A
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1074-80. PubMed ID: 1295762
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
